Epigenetic therapy inhibits metastases by disrupting premetastatic niches

Journal: Nature

Published: 2020-02-26

DOI: 10.1038/s41586-020-2054-x

Affiliations: 18

Authors: 48

Go to article
Institutions Share
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA) 0.45
Johns Hopkins University (JHU), United States of America (USA) 0.25
Beijing Cancer Hospital / School of Oncology, PKU, China 0.13
NIH NCI Center for Cancer Research (CCR), United States of America (USA) 0.02
Anne Arundel Medical Center (AAMC), United States of America (USA) 0.02
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA) 0.02
Medical University of South Carolina (MUSC), United States of America (USA) 0.02
Vanderbilt University Medical Center (VUMC), United States of America (USA) 0.02
The People's Liberation Army General Hospital (PLAGH), China 0.01
University of Illinois at Chicago (UIC), United States of America (USA) 0.01
McMaster University, Canada 0.01
Juravinski Cancer Centre (JCC), HHS, Canada 0.01
Dalian University of Technology (DUT), China 0.01
Fourth Military Medical University (FMMU), China 0.01
Xijing Hospital, China 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER